Evaluation of the effects of passion fruit peel flour (Passiflora edulis fo. flavicarpa) on metabolic changes in HIV patients with lipodystrophy syndrome secondary to antiretroviral therapy  by do Socorro Fernandes Marques, Simone et al.
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This study  evaluated  the  effects  of  using  passion  fruit  peel  ﬂour  together  with  diet  therapy  and  counseling
in  36 patients  with  HIV  lipodystrophy  who  were  in an ambulatory  clinic  in a university  hospital.  The
patients  were  divided  into  two  groups.  One  received  30 g  of  passion  fruit  peel  ﬂour daily  for 90 days  and
diet  therapy  counseling.  The  other  group  received  only diet  therapy  counseling.  The  metabolic  changes
were  analyzed  before  and  after  the intervention,  with  a signiﬁcance  level  predetermined  at  p ≤ 0.05.
The  use  of passion  fruit peel  ﬂour  was  effective  in  reducing  total  cholesterol  and  triacylglycerides  afterIV patients
ipodystrophy syndrome
yslipidemia
30  days.  The  concentrations  of LDL-C  decreased,  while  HDL-C  increased  in  the  blood  of lipodystrophy
patients  after 90  days  passion  fruit  peel  ﬂour  treatment.  No  signiﬁcant  differences  in  food  consumption
were  seen  between  groups.  The  use  of 30 g of  passion  fruit  peel  ﬂour  for  90 days  together  with  diet
therapy  counseling  was  effective  in improving  plasma  concentrations  of  total  cholesterol,  LDL-C,  HDL-C
and triacylglycerides.
Published by Elsevier  Editora  Ltda.  on  behalf  of  Sociedade  Brasileira  de  Farmacognosia.  This  is  an  open
access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).ntroduction
The treatment of acquired immunodeﬁciency syndrome (AIDS)
ith reverse transcriptase and protease inhibitors represented a
ositive impact on the survival rate of individuals carrying the
uman immunodeﬁciency virus, or HIV (Smith, 2014). However,
hen HAART or highly active antiretroviral therapy (Smith, 2015)
ecame a routine treatment, changes in body fat distribution
nd dyslipidemia were observed (Guimarães et al., 2007). These
hanges are called HIV Lipodystrophy syndrome (Tien et al., 2006;
uimarães et al., 2007; Araújo et al., 2007), which can increase the
isk of cardiovascular diseases (Friis-Møller et al., 2003).
∗ Corresponding author.
E-mail: robert.smith@fda.hhs.gov (R.E. Smith).
http://dx.doi.org/10.1016/j.bjp.2016.03.002
102-695X/Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Farm
reativecommons.org/licenses/by-nc-nd/4.0/).Soluble ﬁber may  increase short-chain fatty acid synthesis
(Wong et al., 2006), thereby reducing endogenous cholesterol pro-
duction and associated with a diet low in cholesterol and saturated
fat can reduce blood levels of LDL-C and triacylglycerides (Liu et al.,
2000; Schneeman, 2002; Solà et al., 2007). The American Heart
Association (2006) recommended the use of 5–10 g/day of solu-
ble ﬁber for the reduction of dyslipidemia. A ﬁber-rich diet may
be beneﬁcial in preventing the development of fat deposition in
people with HIV (Hendricks et al., 2003).
Passion fruit is the common name for various species of plants
in the genus Passiﬂora (Zeriak et al., 2010). The two  species with
the most commercial value are P. edulis fo. edulis (red passion fruit)
and P. edulis fo. ﬂavicarpa O. Deg. (yellow), with the yellow species
being the most widely cultivated (Zeriak et al., 2010). It has several
health effects, including lowering the concentrations of LDL-C and
cholesterol in the blood (Ramos et al., 2007). The peels can be dried
acognosia. This is an open access article under the CC BY-NC-ND license (http://
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nd made into a food product called passion fruit peel ﬂour (PFPF)
hat has several health effects and is sold in Brazil as an adjuvant
reatment for diabetes due to its hypoglycemic effect (Smith et al.,
012). Flour prepared from yellow passion fruit peels has also been
hown to reduce blood glucose in diabetic people. In a phase I clin-
cal study, passion fruit peel ﬂour was well tolerated in 36 people
etween ages 20 and 60, of both sexes. They received 10 g of ﬂour
hree times a day and were told to put it in their choice of juice,
oup, or any other food or beverage. There was  an average reduc-
ion of blood glucose, triacylglycerides, total cholesterol and LDL of
.2, 15.0, 18.2 and 19.0%, respectively.
In phase II studies, ﬂour prepared from yellow passion fruit peels
educed blood glucose, cholesterol, LDL, blood pressure and body
eight in diabetic patients.
The peels, or rinds, of Hawaiian yellow passion fruit have been
ed to cattle and found an increase in milk production (Otagaki and
atsumoto, 1958). There are many anecdotal accounts of it increas-
ng milk production and preventing bacterial infection, but these
ffects have not been quantiﬁed.
PFPF contains about 10% moisture, 7.5% ash, 4% protein, 19%
oluble ﬁber, 38% insoluble ﬁber and 21% soluble carbohydrates
Córdova et al., 2005; Pinheiro et al., 2008). The major compound
n PFPF is pectin, a dietary ﬁber that is rich in polygalacturonic acid
nd its methyl ester (Smith et al., 2012). However, to the best of
ur knowledge, the soluble carbohydrates and other soluble com-
ounds have never been identiﬁed or analyzed by either HPLC or
MR.
Thus, considering that PFPF is a good source of soluble ﬁber,
his study evaluated the effectiveness of PFPF in improving the
lood lipid proﬁle of individuals carrying HIV and receiving HAART
ho developed lipodystrophy. In addition, the hot, pressurized
ethanolic extract (100 ◦C and 10 MPa  pressure) was analyzed by
PLC and NMR.
aterials and methods
hemicals
Chloroform (CHCl3), deuterated chloroform (CDCl3), methanol
CH3OH) and deuterated methanol (CD3OD) were from Sigma–
ldrich, St. Louis, MO.
reparation and characterization of the PFPF
The PFPF was produced from sanitized ripe yellow passion fruits
Passiﬂora edulis fo. ﬂavicarpa O. Deg), that were identiﬁed by AUOS-
 and stored at the Federal University of Rio de Janeiro for further
eference. The peel was  separated from the pulp, dehydrated, and
ransformed into ﬂour using a knife mill. In order to character-
ze the PFPF, 10 g of it was mixed with enough HydroMatrixTM
Sigma–Aldrich, St. Louis, MO)  to ﬁll the 100 ml  stainless steel sam-
le cell used in an Accelerated Solvent Extractor (ASE, ThermoFisher
cientiﬁc, Sunnyvale, CA). Then, CH3OH was added while the tem-
erature and pressure were increased to 100 ◦C and 10.3 MPa
1500 psi, 100 atm) over a 3 min  time (static time). Next, the sol-
ent was purged into a collection vessel. A total of four cycles were
un to statically extract the sample, resulting in a total volume of
bout 160 ml.  The solvent was evaporated off and the oily residues
emaining were weighed. A portion of the residue remaining after
vaporating the CH3OH from the methanolic extract of each sample
as redissolved in CD3OD for NMR  analysis. Another portion was
issolved in methanol for HPLC analysis.
NMR  analyses were done using an Agilent DD2 600 MHz  NMR
Santa Clara, CA). A 30◦ pulse width and 1 s pulse delay were used
or the 1H NMR, while a 30◦ pulse width and 2 s pulse delay weresileira de Farmacognosia 26 (2016) 420–426 421
used for the 1H-coupled 13C-NMR spectra, also known as 13C{1H}-
NMR. Chemical shifts were referenced to the CD3OD signals at 3.35
and 4.78 ppm (for 1H) and 49.30 ppm (for 13C) for the spectra of the
methanolic extracts and to the CDCl3 signals at 7.27 and 77.23 ppm,
for 1H and 13C{1H}-NMR, respectively.
The FTIR spectrum of the residue remaining from the methanolic
extract, after evaporating off the methanol was acquired using ATR
attachment on Shimadzu IRAfﬁnity-1S. The UV–Vis spectrum of a
5 g/ml solution of the extract in methanol was obtained using
Shimadzu UV-2600. Plain methanol was used as blank. The source
of light was shifted to deuterium bulb at 300 nm and the spectrum
window was  opened between 900 nm and 185 nm.
Experimental design
A clinical therapeutic randomized trial was  performed
with individuals carrying HIV, presenting Lipodystrophy Syn-
drome, receiving HAART, and showing dyslipidemia (hypercholes-
terolemia, hypertriglyceridemia, or both) as deﬁned by the National
Cholesterol Education Program (2002). These individuals were
monitored at the Lipodystrophy Ambulatory Center in the João
de Barros Barreto University Hospital (HUJBB), during the period
of January to December 2009, and fulﬁlled the criteria for par-
ticipation in the study. The sample was calculated through the
calculation of Proportion: two  samples. For the ﬁrst sample (from
the group using PFPF), the estimated proportion of plasma choles-
terol improvement was  50%; for the second sample, this estimate
was of 10%. The ratio between these samples was stipulated as 1:1.
The power of the test was ﬁxed as 0.8, and the unilateral alpha level
in 0.05. The sample was calculated from sixteen individuals in each
group.
The 36 individuals participating in the study were systemati-
cally divided into two  groups. Group 1 (n = 18) received diet therapy
counseling and 30 g/day of PFPF, consumed as a dilute solution in
water, juices, and/or fruit smoothies. Group 2 (n = 18) received diet
therapy counseling only. There were 12 men  and 6 women  in each
group.
Information about pathology, weight, height, and food intake
was assessed in the initial evaluation by the 24 h recording method
(R24) at the time of the initial (beginning of the intervention) and
last assessments (end of the study).
Individuals from the two  groups were instructed to have bio-
chemical tests performed monthly (total cholesterol – TC, LDL-C,
HDL-C, and triacylglycerides) at the HUJBB’s laboratory. These tests
were performed in the morning, after 12 h fasting and at 4 time
points in the study: before the intervention (T0), at 30 (T30), 60
(T60), and 90 days (T90) after the intervention.
The following parameters were followed as inclusion criteria
in the study: be an adult patient (any gender) receiving HAART,
attending treatment at the Lipodystrophy ambulatory center at
the HUJBB, presenting changes in the TC and/or LDL-C and/or tri-
acylglycerides, presenting undetectable HIV viral load and LTCD4+
above 300 cells/mm3 and agreeing to participate in the study by
voluntarily signing an informed consent form.
The following criteria were followed for study exclusion: indi-
viduals presenting triacylglycerides above 700 mg/dl, or using
lipid-lowering drugs, who could not complete the 90 days of mon-
itoring, did not tolerate the use of PFPF, missed appointments,
displayed mental illness, were under age 18 (children, and ado-
lescents), and did not accept to participate in the study.
The data obtained were tabulated and analyzed using the Bio-
stat 5.0 program (2007) with a signiﬁcance level of p ≤ 0.05. The
dietpro program (Esteves and Monteiro, 2002) was used for the
evaluation of R24 h. The bilateral t-test was used for the veriﬁca-
tion of homogeneity in the observed values between the groups.
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Fig. 2. UV–Vis spectrum of the hot, pressurized methanolic extract (100 ◦C and
10  MPa  pressure) of passion fruit peel ﬂour, in methanol. The maximum at 270 nm
can  be used to help identify the passion fruit peel ﬂour.
CD3OD CD3OD
CHO and CH2O of
carbohydrates22 S. do Socorro Fernandes Marques et al. / Revis
he paired t-test was used to assess the variation in the results
rom laboratory tests.
The study was conducted according to the guidelines laid down
n the Declaration of Helsinki and Nuremberg Code respecting the
tandards of research involving human subjects (resolution 196/96)
f the National Health Council. This study was authorized by the
thics Committee for Research with Human Beings of the HUJBB
rom the Federal University of Pará under Protocol No. 1945/08.
ritten informed consent was obtained from all patients.
This research received no speciﬁc grant from any funding agency
n the public, commercial or not-for-proﬁt sectors.
esults
Dry methanol at 100 ◦C and 10 MPa  (100 atm) pressure in a
ealed container solubilized 31% of the PFPF. The FTIR spectrum of
he residue remaining after evaporating off the methanol is shown
n Fig. 1. The peaks in the region from 1400 to 1800 cm−1 are
isted in Table 1. The UV–Vis spectrum of a 5 g/ml solution of the
xtract in methanol is shown in Fig. 2. The 1H and 13C{1H}-NMR
pectra of the extract are shown in Figs. 3 and 4. The 13C chemical
hifts are tabulated in the Supplementary Material. Signals due to
he CHO and CH2O of carbohydrates accounted for 75.9% of the
otal peak area (Fig. 1). There were also signals due to CH3(CH2)n
roups in fatty acyls that are covalently bound to carbohydrates
s fatty acid glycosides in both the 1H and 13C{1H}-NMR spectra
Figs. 1 and 2). On the other hand, several of the signals that
re produced by d-fructose were not seen, including the ones at
05.93, 99.30, 84.24, 83.31, 77.60, 76.84, 71.93, 66.00, 65.19 and
4.28 ppm. So, even though d-fructose is soluble in methanol,
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ig. 1. FTIR spectrum of the hot, pressurized methanolic extract (100 ◦C and 10 MPa
ressure) of passion fruit peel ﬂour, after evaporating off the methanol. The peaks
an be used as a type of ﬁngerprint that can be used to identify it.
8 7
HC = of aromatic
compounds
(CH2)n
CH3
6 5 4 3 2 1 ppm
Fig. 3. 1H NMR of the hot, pressurized methanolic extract (100 ◦C and 10 MPa  pres-
sure) of passion fruit peel ﬂour. The signals can be used as a type of ﬁngerprint that
can  be used to identify it.
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Fig. 4. 13C{1H}-NMR of the hot, pressurized methanolic extract (100 ◦C and 10 MPa
pressure) of passion fruit peel ﬂour. The signals can be used as a type of ﬁngerprint
that can be used to identify it.
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Table  1
Peaks in the FTIR spectrum of the hot, pres-
surized methanolic extract (100 ◦C and 10 MPa
pressure) of passion fruit peel ﬂour.
cm−1 cm−1
1796 1610
1792 1609
1785 1603
1781 1595
1723 1591
1767 1577
1762 1570
1757 1565
1751 1559
1749 1555
1744 1549
1740 1540
1734 1533
1730 1528
1723 1521
1719 1517
1716 1507
1707 1499
1700 1497
1696 1490
1684 1481
1681 1477
1676 1473
1669 1465
1663 1458
1654 1448
1647 1437
1636 1430
1628 1424
1624 1420
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Table 2
Effects of PFPF on the plasma concentrations of cholesterol, LDL-C, HDL-C and TG in
HIV  patients with lipodystrophy syndrome secondary.
Variable Group 1 Group 2 p value
Average SD Average SD
Age (years) 46.0 8.4 46.6 7.0 0.83
Time since diagnosis (years) 9.1 4.9 11.0 5.4 0.28
Duration of HAART (years) 8.2 4.5 10.0 5.0 0.25
Weight (kg) 59.7 10.1 57.5 10.4 0.52
BMI  (kg/m2) 23.3 2.8 22.1 3.5 0.28
There were 12 men  and 6 women in each group. The data obtained were tabu-
lated and analyzed using the Biostat 5.0 program (2007) with a signiﬁcance level of
p  ≤ 0.05. The dietpro program (Esteves and Monteiro, 2002) was used for the eval-
uation of R24 h. The bilateral t-test was used for the veriﬁcation of homogeneity in
levels of triacylglycerides in just the ﬁrst 30 days and maintaining
this lower level throughout the study.
Table 3
Averages and standard deviations and differences between the average values of
the evaluated parameters during the intervention in Group 1 (which received diet
therapy counseling and 30 g/day of PFPF). Comparison between the basal values and
values observed in other periods throughout the study.
Evaluation Difference between averages (SD)
Average SD T0/T30 T0/T60 T0/T90
TC
T0 227.3 42.9 26.8 (40.8) 34.5 (27.4) 35.2 (39.5)
T30  200.6 51.2 p = 0.007a p < 0.0001a p = 0.001a
T60 192.8 45.5
T90 192.1 45.2
LDL-C
T0 125.8 33.1 13.2 (36.4) 14.5 (32.6) 32.3 (34.72)
T30  112.6 47.7 p = 0.14 p = 0.1 p = 0.0082a
T60 111.3 42.6
T90 93.5 45.8
HDL-C
T0 43.9 12.2 −1.1 (9.2) 0.6 (9.7) −5.9 (10.7)
T30 44.8 16.9 p = 0.33 p = 0.4 p = 0.0294a
T60 43.1 13.9
T90 49.7 19.1
TG
T0 323.9 114.4 68.6 (140.3) 97.7 (149.1) 96.47 (164.6)
T30 255.2 115.2 p = 0.034a p = 0.0078a p = 0.0140a
T60 226.1 118.4
T90 227.4 139.3
TC, total cholesterol; TG, triacylglycerides.
a p-value < 0.05. The data obtained were tabulated and analyzed using the Bio-
stat  5.0 program (2007) with a signiﬁcance level of p ≤ 0.05. The dietpro program1617 1412
t is not present at a sufﬁcient concentration to be detected by
3C{1H}-NMR. Glucose and sucrose are not soluble in methanol,
ut are not known to be in PFPF, which does not have a sweet taste.
till, there is a signiﬁcant concentration of fatty acid glycosides
n the methanolic extract of PFPF. They produced not only signals
ue to CH3(CH2)n, but also the carbonyl carbon due to esters at
70.397 and 172.635 ppm. There is also at least one free fatty acid,
s indicated by the carbonyl carbon at 181.573 ppm. Finally, there
re also signals due to HC CR carbons and protons due to aromatic
ompounds in the 1H and 13C{1H}-NMR spectra.
As shown in the Supplementary Material, analysis by HPLC sup-
orts the hypothesis that there are aromatic compounds.
Out of the 41 individuals selected to participate in the study,
hree were eliminated from Group 1 (two reported unpleasant
aste when using PFPF, and one initiated the use of lipid-lowering
rugs during the study). In Group 2, two patients were eliminated
one initiated the use of lipid-lowering drugs, and one missed
ubsequent appointments). Thirty-six patients remained in the
tudy and were evaluated. Table 2 describes the characteristics of
he patients. The statistical analysis demonstrated no difference
etween the groups according to the evaluated variables. The aver-
ge values for TC, LDL-C, HDL-C, and triacylglycerides are presented
n Tables 3 and 4 for patients in Group 1 and 2, respectively.
The increase in HDL-C, in the group using PFPF during 90 days
veraged 5.9 ± 10.7 mg/dl, which corresponded to 13.4% of the ini-
ial value. On the other hand in Group 2, the increase averaged
 ± 10.4 mg/dl and corresponded to 2.3% of the initial value.
The average value (Table 3) for basal total cholesterol detected
n Group 1 (227.3 ± 42.9 mg/dl) is considered a borderline value
ccording to the NCEP III (2003), however, after 90 days of inter-
ention with PFPF, this value decreased to 192.1 ± 45.2 mg/dl,
hich is classiﬁed as optimal. This reduction was highly signiﬁcant
p = 0.001) and already noticed as a signiﬁcant decrease 30 daysthe observed values between the groups. The paired t-test was  used to assess the
variation in the results from laboratory tests.
after the intervention (p = 0.007). The LDL concentrations in indi-
viduals who used PFPF during 30 and 60 days showed discrete and
non-signiﬁcant reduction. A signiﬁcant LDL-C reduction was only
observed after 90 days of intervention (p = 0.0082).
A discrete and not signiﬁcant elevation in the HDL-C concentra-
tions were observed in individuals who  used PFPF during 30 days;
however, a signiﬁcant increase was observed after 90 days of its
use (p = 0.0294). There were no signiﬁcant changes in the HDL-C
concentrations in Group 2 throughout the intervention period.
The plasma triacylglycerides concentrations decreased signiﬁ-
cantly (p = 0.034) after 30 days of PFPF consumption together with
diet therapy counseling. However, there was no further signiﬁcant
reduction afterwards, showing that PFPF assisted in reducing the(Esteves and Monteiro, 2002) was used for the evaluation of R24 h. The bilateral
t-test was  used for the veriﬁcation of homogeneity in the observed values between
the  groups. The paired t-test was  used to assess the variation in the results from
laboratory tests.
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Table 4
Averages and standard deviation and differences between the average values of
the  evaluated parameters during the intervention in Group 2 (which received diet
therapy counseling only). Comparison between the basal values and values observed
in  other periods throughout the study.
Evaluation Difference between averages (SD)
Avg SD T0/T30 T0/T60 T0/T90
TC
T0 234 59.7 8.8 (36.2) 7.0 (26.3) 4.83 (35.4)
T30  226 56.7 p = 0.16 p = 0.14 p = 0.28
T60  228 55.3
T90 230 50.1
LDL-C
T0 143 52.6 16.9 (49.5) 18.5 (51.8) 12.7 (34.0)
T30  126 51.6 p = 0.11 p = 0.10 p = 0.09
T60  125 45.8
T90 131 42.5
HDL-C
T0 43.6 16.5 −0.6 (10.6) 2.77 (7.8) −1 (10.4)
T30 44.2 17.3 p = 0.40 p = 0.09 p = 0.35
T60  40.9 14.9
T90 44.6 17.7
TG
T0 294 120.4 −16.2 (131.4) 5.33 (72.3) −7.94 (118.9)
T30  310 137.4 p = 0.30 p = 0.38 p = 0.39
T60  288 115.9
T90 302 153.6
TC, total cholesterol; TG, triacylglycerides.
The data obtained were tabulated and analyzed using the Biostat 5.0 program (2007)
with a signiﬁcance level of p ≤ 0.05. The dietpro program (Esteves and Monteiro,
2002) was  used for the evaluation of R24 h. The bilateral t-test was used for the
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teriﬁcation of homogeneity in the observed values between the groups. The paired
-test was  used to assess the variation in the results from laboratory tests.
Table 5 shows the evaluation of effects from the consumption
f macronutrients and dietary ﬁbers, constituents of the diet used
n the study, before and after intervention. There was no difference
n the constituents of the diet between the groups, this conﬁrming
he effects of the PFPF in the obtained results.
able 5
verage and standard deviation of the consumption levels of the main food compo-
ents, before and after intervention, in Groups 1 and 2.
Nutrients Group 1 Group 2 p-value
Average SD Average SD
Calories (kcal)
Before 2190 688 2265 830 0.77
After 1883 499 1804 670 0.69
Saturated fat (g)
Before 16.9 7.9 16.0 6.7 0.70
After 13.3 7.0 14.5 13.7 0.74
Monounsaturated fat (g)
Before 16.5 7.4 18.5 9.2 0.47
After 12.4 8.0 14.3 10.3 0.56
Polyunsaturated fat (g)
Before 11.8 9.1 16.7 15.5 0.25
After 5.9 4.7 5.7 4.4 0.87
Cholesterol (mg)
Before 354.6 304 383 327 0.79
After 184.7 120 221 191 0.50
Fibers (g)
Before 32.7 55.5 29.6 20.7 0.48
After 36.6 56.4 32.7 7.1 0.62
he data obtained were tabulated and analyzed using the Biostat 5.0 program (2007)
ith a signiﬁcance level of p ≤ 0.05. The dietpro program (Esteves and Monteiro,
002) was  used for the evaluation of R24 h. The bilateral t-test was used for the
eriﬁcation of homogeneity in the observed values between the groups. The paired
-test was  used to assess the variation in the results from laboratory tests.sileira de Farmacognosia 26 (2016) 420–426
Discussion
To the best of our knowledge, this is the ﬁrst report that
describes the FTIR, UV–Vis and NMR  analysis of PFPF. Hot, pres-
surized, dry methanol was chosen as the solvent to extract the
PFPF, because previous studies have shown that it is better than
ultrasound, Soxhlet extraction or other methods for solubilizing
solids in fruits (Richter et al., 1996; Richards et al., 2014). Dry
methanol at 100 ◦C and 10 MPa  (100 atm) pressure in an acceler-
ated solvent extractor was  able to solubilize d-fructose, fatty acid
glycosides and other compounds from a variety of fruits (Richards
et al., 2014). d-fructose produced more than six signals, because it
exists as a mixture of three isomers in methanol: -fructopyranose,
-fructofuranose and -fructofuranose (Richards et al., 2014). Fatty
acid glycosides have been shown to have important neuromodula-
tory effects (Akihisa et al., 2007; Li et al., 2008; Smith, 2015).
The FTIR spectrum had a large, broad peak from about 3000 to
3500 cm−1. This indicates the presence of hydroxyl groups (Smith,
2014). There were also peaks from 1650 to 1780, and 1600 to
1650 cm−1 due to C O and C O bonds, respectively (Smith, 2014).
The UV spectrum had maximum absorbance (max) at 205 and
270 nm.  The max at 270 nm indicates the presence of one or more
aromatic compounds. The 1H and 13C{1H}-NMR spectra contained
signals from about 3.0 to 5.4 ppm and 64 to 110 ppm, respectively,
due to CHO and CH2O groups in carbohydrates. Fructose is the only
simple sugar that dissolves in methanol. However, PFPF does not
taste sweet and there were several signals that fructose is known
to produce in 13C-NMR spectra (Richards et al., 2014) that were
not seen in the spectrum. Also, there were signals from 0.6 to
1.0 ppm and 14.5 to 34 ppm in the 1H and 13C{1H}-NMR spectra
due to the CH3 and (CH2)n of fatty acyl groups. This supports the
hypothesis that PFPF contains fatty acid glycosides. There were sig-
nals from about 6.8 to 8.2 ppm and 128 to 136 ppm in the 1H and
13C{1H}-NMR spectra due to C C and HC C bonds. This is consis-
tent with the UV spectrum that showed the presence of aromatic
compounds. Finally, there were signals in the 13C{1H}-NMR spec-
trum from about 171 to 182 ppm due to C O bonds in esters and
carboxylic acids. The FTIR spectrum is a good ﬁngerprint of the PFPF,
while the UV and NMR  spectra were also quite informative.
A clinical trial was conducted in women  presenting dyslipide-
mia  (Ramos et al., 2007) using the same 30 g/day dose of PFPF that
was used in the present study. Similar reductions in the concen-
trations of cholesterol in the blood were seen (Ramos et al., 2007).
A reduction of 31.7 ± 28.0 mg/dl in this value was  observed after
30 days of intervention and 47.0 ± 29.5 mg/dl after 60 days (Ramos
et al., 2007). Both were statistically signiﬁcant, with p = 0.0001 and
p = 0.0000, respectively (Ramos et al., 2007).
In another open clinical trial was  conducted on 36 healthy adults
of both genders, who were instructed to eat 10 g of PFPF three times
a day, daily for during eight weeks (Medeiros et al., 2009). A sig-
niﬁcant reduction in total cholesterol concentrations in the blood
(17.0% for women and 19.5% for men) was observed (Medeiros et al.,
2009).
Elevated total cholesterol is a risk factor for developing cardio-
vascular disease (Smith, 2015). This has become more frequent
among HIV+ individuals who  receive HAART drug therapy. Car-
diovascular diseases are the leading cause of death in the US, but
their incidence can be lowered by taking drugs like statins that
reduce blood cholesterol levels (Smith, 2015), and by consuming
more dietary ﬁber (Brown et al., 1999). The National Cholesterol
Education Program in the USA (2002) estimated that for every 1%
reduction in cholesterol concentration in the blood, a decrease of
2% in the risk of cardiovascular diseases could be observed.
PFPF may  improve the concentrations of cholesterol, LDL-C,
HDL-C and triacylglycerides in several ways. First, it can make one
feel satiated and eat less. Moreover, dietary ﬁber can improve the
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omposition of healthy bacteria in the gut, with concomitant health
ffects. Finally, the fatty acid glycosides may  be able to boost the
mmune system, reduce smoldering inﬂammation, which can help
revent cardiovascular and neurodegenerative diseases as well as
ancer (Smith, 2015).
The reduction of LDL-C observed in this study is similar to the
esults observed by others (Ramos et al., 2007) who  saw a decrease
f 33.6 ± 33.3 mg/dl in the LDL-C (p = 0.0003) when introducing 6 g
f soluble ﬁber in the usual diet of 52 women. One study eval-
ated the introduction of 14 g of ﬁber per day in women living
n a community in Fort Collins and there was an 8% reduction in
he amounts of LDL-C after 90 days of follow-up, lower than the
resent study that the decrease was on average 32.3 ± 34.7 mg/dl
n group 1 which equals 25.6% (Davy et al., 2002). A meta-analysis
as performed on the effects of ﬁber intake on cholesterol levels
nd concluded, that the increase in soluble ﬁber in the diet, produce
igniﬁcant results on the LDL-C values (Brown et al., 1999).
LDL-C is the primary lipoprotein in the plasma, acts as a choles-
erol transporter and seems to be the most atherogenic of all
Goldstein and Brown, 1977). The deposition of cholesterol is a con-
equence of oxidation of circulating cholesterol-rich lipoproteins,
n particular LDL-C (Steinber, 1997; Cobbold et al., 2002). Thus,
he NCEP has identiﬁed this lipoprotein as the main target in the
reatment of dyslipidemia (NCEP, 2002). The increase in LDL-C lev-
ls promotes atherogenesis however, the restoration of the ideal
erum levels reduces the risk of atherosclerotic cardiovascular dis-
ase signiﬁcantly even in patients who already present advanced
athology (Grundy et al., 2004; Tabas et al., 2007). The reduction
f 39 mg/dl in this lipoprotein level reduces in 30% the relative risk
or developing coronary artery disease (Grundy et al., 2004).
It was found that adults of both sexes who received 30 g of
FPF daily for eight weeks had signiﬁcantly lower average HDL-C
oncentrations at the end of the study compared to the beginning
Janebro et al., 2008). This pattern was also observed in the present
tudy, in both fourth and eighth week. The values reached the nor-
al  range for both women and men  in this latest evaluation, and the
espective averages were 53.50 ± 10.8 mg/dl and 43.2 ± 8.13 mg/dl
Janebro et al., 2008).
The results from the Veterans Affairs High-Density Lipoprotein
ntervention Trial reinforced the idea that elevated HDL-C can
educe the risk of coronary disease (Rubins et al., 2000). In this
tudy, the 22% reduction in deaths from coronary events or non-
atal myocardial infarctions was correlated to the reduction in
holesterol and triacylglycerides levels, by 4% and 31%, respectively,
nd in the increase of HDL-C by 6%, without signiﬁcant changes
n LDL-C (Rubins et al., 2000). It should be emphasized that in
he present study, the HDL-C in the group using PFPF increased
rom 43.9 ± 12.2 mg/dl at day zero to 49.7 ± 19.1 after 90 days
Table 3). On the other hand HDL-C changed from 43.6 ± 16.5 to
4.6 ± 17.7 mg/dl after 30 days.
Despite the ﬁbers not interfering directly in the HDL-C levels,
his lipoprotein varies in a reversed way with the triacylglycerides
Vega et al., 2014). The reduction in lipolysis of the lipoproteins
ich in triacylglycerides lowers the levels of available substrate for
he maturation of HDL-C (de Man  et al., 2003). In addition, the
nrichment of HDL-C with triacylglycerides increases the catabolic
ate and therefore, reduces its plasma concentration. Also, the lipid
xchange between HDL-C and the lipoproteins rich in triacylglyc-
rides are reduced leading to a faster disappearance of the plasma
DL-C (Genest et al., 2006). For each 1% increase in HDL-C there
as a 1% reduction in coronary events regardless of the variation
f LDL-C, because HDL-C promotes the esterﬁcation of cholesterol
nd protects the arteries due to the reverse transport of choles-
erol. This promotes the withdrawal of cholesterol from the tissues
eripheral to the liver where it is excreted in the bile (Abbott et al.,
988; Barter, 2004; Daminelli et al., 2008).sileira de Farmacognosia 26 (2016) 420–426 425
In agreement with the present study, 43 volunteers who
received 30 g/day PFPF experienced a signiﬁcant reduction in tria-
cylglycerides after 8 weeks using this ﬂour. The average values fell
from 212.0 ± 119.3 to 161.2 ± 91.1 mg/dl (Janebro et al., 2008).
Hypertriglyceridemia is an independent risk factor for athero-
genesis, stroke, and acute myocardial infarction. It was observed in
a meta-analysis with seventeen prospective epidemiological stud-
ies that every increase of 89 mg/dl in the triglyceridemia led to an
increase in the risk of cardiovascular disease of 32% and 76% in
men  and women, respectively (Abbott et al., 1988). The higher the
triglyceridemia, the greater the formation of LDL-C type B, which
are smaller and denser. This is important because small and dense
LDL-C particles may  be more susceptible to oxidative modiﬁcation.
Also, an increased number of atherogenic particles may adversely
inﬂuence cardiovascular risk (Passareli et al., 2007; Miller et al.,
2011).
Conclusion
It was  concluded that the use of 30 g of passion fruit peel ﬂour
during 30 days together with diet therapy counseling was effective
in reducing cholesterol and triacylglycerides levels. PFPF treatment
showed good effects against lipodystrophy in HIV patients treated
for 90 days. The use of this product for 90 days was effective in
reducing the LDL-C, and increasing the HDL-C values in individuals
presenting HIV Lipodystrophy syndrome and dyslipidemia. PFPF
was found to contain methanol-soluble fatty acid glycosides and
aromatic compounds when analyzed by NMR. FTIR and UV–Vis
spectra are also useful in establishing a “ﬁngerprint” of PFPF.
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